Explanipedia

A IMPLEMENTAÇÃO DA PROFILAXIA PRÉ-EXPOSIÇÃO (PREP) E PÓS EXPOSIÇÃO (PEP) NO SUS: DESAFIOS, IMPACTOS E PERSPECTIVAS NA PREVENÇÃO AO HIV Open

Igor Henrique Rodrigues Oliveira, A. Moreira, Áurea J. Chaves, Mariana Favero Elias, Luane Magalhães Pinheiro , et al. · 2024

Introdução: A implementação da Profilaxia Pré-Exposição (PrEP) e da Profilaxia Pós-Exposição (PEP) no Sistema Único de Saúde (SUS) foi um marco na luta contra o HIV no Brasil, reforçando os princípios de universalidade, integralidade e equ…

Aspirin versus P2Y12 inhibitors for secondary prevention after percutaneous coronary intervention Open

Luiz Fernando Tanajura, Áurea J. Chaves, Rafaela Andrade Penalva Freitas, Ana Barbosa, K. Vital , et al. · 2023

Currently, percutaneous coronary intervention with a drug-eluting stent implantation is the main method of myocardial revascularization in tertiary care hospitals, regardless of the clinical presentation of coronary artery disease. It is w…

PB0856 Time Course of Thrombocytopenia during DDAVP Test in a Boy with a De Novo c.4121G>A ( p.Arg1374His) Variant of the VWF Gene Open

Juan Pablo Frontroth, Mirta Hepner, Carolina Pepe, Áurea J. Chaves, S. Annetta , et al. · 2023

P2Y12 inhibitor de-escalation after percutaneous coronary interventions Open

Luiz Fernando Tanajura, Áurea J. Chaves, Rafaela Andrade Penalva Freitas, J. Ribamar Costa · 2023

In patients who have acute coronary syndromes and are treated with percutaneous coronary intervention, the prescription of a dual antiplatelet regimen, consisting of acetylsalicylic acid and a P2Y12 receptor inhibitor, is mandatory, contri…

Percutaneous coronary intervention in the patient at high risk of bleeding Open

Luiz Fernando Tanajura, Áurea J. Chaves, J. Ribamar Costa, Sergio Luiz Navarro Braga · 2022

Currently, percutaneous coronary interventions account for more than 80% of myocardial revascularization procedures. This result was enabled by two major advances: the development of effective and safe drugeluting stents, in addition to a…

Monotherapy with P2Y12 receptor inhibitors in patients treated by percutaneous coronary intervention Open

Luiz Fernando Tanajura, Áurea J. Chaves, Andrea Abizaid, J. Ribamar Costa · 2021

Since the mid-1990s, the dual antiplatelet therapy, consisting of the association between acetylsalicylic acid and a platelet P2Y12 receptor inhibitor, is the core of thrombosis prevention after coronary stent implantation, regardless of t…

Prasugrel versus ticagrelor in acute coronary syndromes Open

Luiz Fernando Tanajura, J. Ribamar Costa, Áurea J. Chaves, Marinella Centemero, Fausto Feres · 2021

Acute coronary syndromes are common situations in medical practice, with high morbidity and mortality. Consequent to its relevance, its clinical management has always been subject of discussion and controversy. Since the past decade, the d…

Pregnancy-associated spontaneous coronary artery dissection: insights from a case series of 13 patients Open

Jamil Cade, Gilberto Szarf, Maria Eduarda Menezes de Siqueira, Áurea J. Chaves, Júlio Andrea , et al. · 2016

In these 13 cases of P-SCAD, clinical presentation commonly included acute myocardial infarction and cardiogenic shock. Multivessel dissections and involvement of the left coronary artery and left main coronary artery were highly prevalent…

Results of primary percutaneous treatment of acute myocardial infarction at a reference hospital in southern Brazil Open

Áurea J. Chaves · 2016

Resultados do tratamento percutâneo primário do infarto agudo do miocárdio em um hospital de referência do sul do Brasil Open

Áurea J. Chaves · 2016

Long-Term Follow-Up of Patients after Percutaneous Coronary Intervention with Everolimus-Eluting Bioresorbable Vascular Scaffold Open

Rafael Alexandre Meneguz‐Moreno, J. Ribamar Costa, Freddy Antonio Brito Moscoso, Rodolfo Staico, Luiz Fernando Tanajura , et al. · 2016

Nesta análise preliminar, o uso do SVB Absorb® mostrou-se seguro e eficaz no seguimento bastante tardio. Faz-se necessário estabelecer o perfil de eficácia e segurança destes dispositivos em cenários de maior complexidade.

Early and late clinical outcomes after saphenous vein graft treatment with MGuard TM stents vs. drug-eluting stents Open

Danillo Taiguara da Silva, J. Ribamar Costa, Antônio de Castro Filho, Rodolfo Staico, Ricardo A. Costa , et al. · 2015

The MGuardTM stent, which has a microscopic polymer mesh coating, is intended to reduce the distal embolization of fragments during percutaneous coronary intervention (PCI) in saphenous vein grafts (SVG). This study evaluated the early and…

Dispositivos de nova geração para substituição da válvula aórtica transcateter Open

Áurea J. Chaves · 2015

Desfechos clínicos precoces e tardios após tratamento de enxertos de veia safena com stents MGuard™ vs. stents farmacológicos Open

Danillo Taiguara da Silva, J. Ribamar Costa, Antônio de Castro Filho, Rodolfo Staico, Ricardo A. Costa , et al. · 2015

O stent MGuard™, revestido por malha polimérica microscópica, tem a finalidade de reduzir a embolização distal de fragmentos durante a intervenção coronária percutânea (ICP) em enxertos de veia safena (EVS). Avaliamos os desfechos clínicos…

New generation devices for transcatheter aortic valve replacement Open

Áurea J. Chaves · 2015

Em busca de resultados ótimos para procedimentos transcateter aórticos valve‐in‐valve Open

Áurea J. Chaves · 2015

In search for optimal results for transcatheter aortic valve-in-valve procedures Open

Áurea J. Chaves · 2015

Intervenções transcateter em doenças cardíacas valvares Open

Áurea J. Chaves · 2015

Transcatheter interventions in valvular heart disease Open

Áurea J. Chaves · 2015

Efficacy of Patient Selection for Diagnostic Coronary Angiography in Suspected Coronary Artery Disease Open

Francisco Flávio Costa Filho, Áurea J. Chaves, Lourenço Teixeira Ligabó, Eduardo Moreira dos Santos, Danillo Taiguara da Silva , et al. · 2015

In this study, less than a quarter of the patients referred for coronary angiography with suspected CAD had the diagnosis confirmed. A better clinical and non-invasive assessment is necessary, to improve the efficacy of patient selection f…

RBCI versão 2015 Open

Áurea J. Chaves · 2015

Resposta vascular após implante de stents liberadores de biolimus A9 com polímero bioabsorvível e stents liberadores de everolimus com polímero durável. Resultados da análise de tomografia de coerência óptica do estudo randomizado BIOACTIVE Open

Daniel Chamié, Breno Oliveira Almeida, Fábio Grandi, Evandro Martins Filho, J. Ribamar Costa , et al. · 2015

No estudo BIOACTIVE, avaliamos as respostas vasculares após implante do stent eluidor de biolimus A9 (SEB; BioMatrix®) e o stent eluidor de everolimus (SEE; XIENCE V®). Apresentamos a análise de tomografia de coerência óptica (OCT) 6 meses…

Vascular response after implantation of biolimus A9-eluting stent with bioabsorbable polymer and everolimus-eluting stents with durable polymer. Results of the optical coherence tomography analysis of the BIOACTIVE randomized trial Open

Daniel Chamié, Breno Oliveira Almeida, Fábio Grandi, Evandro Martins Filho, J. Ribamar Costa , et al. · 2015

In BIOACTIVE study, we evaluated vascular responses after the implant of biolimus A9-eluting stent (BES; BioMatrixTM) and the everolimus-eluting stent (EES; XIENCE VTM). In this study, we present the optical coherence tomography analysis (…

Áurea J. Chaves YOU? Author Swipe